Close Close
ThinkAdvisor

Life Health > Life Insurance

Club Vita Forms COVID-19 Lifespan Impact Research Panel

X
Your article was successfully shared with the contacts you provided.

A firm that helps the pension plan community figure out how long plan participants will live is starting a COVID-19 analysis project.

The firm, Club Vita, has set up a research advisory panel.

(Related: 50 States of New Total Death Ratio Data)

The panel will look at how COVID-19 and other new or poorly understood factors are affecting pension plan participants’ longevity, the firm announced earlier this week.

Club Vita is hoping that panel members will help COVID-19 sift through academic research, and use Club Vita’s own data and analytical tools, to give pension actuaries a good idea of what’s really happening now to plan participants.

Pension plans use Club Vita data to manage plan finances, and to structure arrangements for transferring pension risk to life insurers through the purchase of group annuities.

Jennifer Haid, the chief executive officer of Club Vita, is the chair of the new Club Vita advisory panel.

The other members include prominent members of the pension analysis community, such as Doug Anderson, who’s the executive director of the Minnesota Public Employees Retirement Association; Magali Barbieri, a demographics researcherat the University of California; Bruce Cadenhead, the chief actuary at Mercer; Eli Greenblum, the chief actuary at Segal Consulting; Dr. Sadhna Paralkar, the national medical director at Segal; Phil Rivard, a vice president with the Pension Policy and Funding Local Authorities Pension Plan in Edmonton Alberta, Canada; Dan Ryan, chief science officer at COIOS Research; and Jay Vivian, the former chief investment officer for IBM’s retirement plans.

Haid said in a comment about the advisory panel that she hopes the panel will help Club Vita come up with ideas for keeping pension plan participants healthy, and ideas for steps government agencies could take to make things better.

— Read COVID-19 Trackers Face After-Effects Data Gapon ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on FacebookLinkedIn and Twitter.